Company: PRME
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001628280-25-018704
Chunk: 31

Company: Prime Medicine, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 31
---
                                                 |     | $ |  7,500 |
| Additional Retainer for Nominating and Corporate Governance Committee |     |   |        |
| Chair                                                                 |     | $ | 10,000 |
| Non-chair members                                                     |     | $ |  5,000 |

(1) The annual retainer for board membership was increased by our Board in May 2024 from $40,000 to $45,000.

(2) The additional annual retainer of $30,000 for the chair of our Board was approved by our Board in May 2024.

(3) The annual retainer for the chair of the audit committee was increased by our Board in May 2024 from $15,000 to $20,000.

(4) The annual retainer for members of the audit committee was increased by our Board in May 2024 from $7,500 to $10,000.

(5) The annual retainer for the chair of the compensation committee was increased by our Board in May 2024 from $12,000 to $15,000.

(6) The annual retainer for members of the compensation committee was increased by our Board in May 2024 from $6,000 to $7,500.

In addition, our policy provides that, upon initial election or appointment to our Board, each new non-employee director will be granted a one-time grant of a non-statutory stock option to purchase shares of our common stock equivalent to $800,000 in value on the date of such director’s election or appointment to the Board (the “Initial Director Grant”); provided that the maximum number of shares of our common stock subject to each such option shall be 90,000 shares. The Initial Director Grant will vest in substantially equal annual installments over three years, subject to the non-employee director’s continued services to the Company. On the date of each annual meeting of stockholders of the Company, each non-employee director who will continue as a non-employee director following such meeting, other than a non-employee director receiving an Initial Director Grant, will be granted an annual award of a non-statutory stock option to purchase shares of common stock equivalent to $400,000 in value (the “Annual Director Grant”); provided that the maximum number of shares of our common stock subject to each such option shall be 45,000 shares. Notwithstanding the foregoing, if a non-employee director was initially elected to our Board on a date other than